Roberto Jappelli

Roberto Jappelli, a Principal Scientist at Abilita Therapeutics, Inc., has a strong background in research and scientific roles. With experience in various companies and research institutes, including Salgomed, Sanford Burnham Prebys Medical Discovery Institute, and Salk Institute for Biological Studies, Roberto has a solid foundation in the field. Their educational background includes a Doctor of Philosophy (PhD) in Cellular and Molecular Biology from the University of Rome Tor Vergata.